focus -WSS

focus

author：focus 2025-09-27 12:47:54 - browse：89987

Sammy Kimball for STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Teladoc has a new CEO, but challenges remain the same

WSS

Doctors on social media are being harassed and cyberbullied

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Medical device trials still don't enroll enough women, study finds

Tome Biosciences co

Statins may not be needed by millions of people, study suggests

Congress might make insulin pumps more accessible to the blind

Wikipedia

focus

focus

Tori Bowie and the unacceptable rates of Black maternal death

Medical device trials still don't enroll enough women, study finds

Affirmative action in medical school literally saved lives

Pharma companies must ensure equitable access to obesity drugs

Dobbs anniversary: the lost opportunity of abortion as health care

STAT Boddities: What happens to the brain when we get scared?

Jerome Adams on the need for new antivirals for Covid

Congress considering partial increase for doctor pay in Medicare

The high cost of giving birth even with insurance

Study: Why relieving medical debt did not improve financial outcomes

focus

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

'Essentially witchcraft:' A former naturopath takes on the field

Why Eli Lilly’s earnings didn’t quite live up to the hype

Statins may not be needed by millions of people, study suggests

Congress might make insulin pumps more accessible to the blind

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

knowledge

entertainment

focus

hotspot